$RLFTF Zyesami is the ONLY drug that has shown a benefit in critical to severe in a triple blind placebo controlled study. When people hear of this, these shares are going to fly. Moderna trades with a 162 PE. With the inhaler, we will also be a household name.
1
5
5 Likes